Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

Buried in the Middle, But Guilty: Intronic Mutations in the TCIRG1 Gene Cause Human Autosomal Recessive Osteopetrosis.

Palagano E, Blair HC, Pangrazio A, Tourkova I, Strina D, Angius A, Cuccuru G, Oppo M, Uva P, Van Hul W, Boudin E, Superti-Furga A, Faletra F, Nocerino A, Ferrari MC, Grappiolo G, Monari M, Montanelli A, Vezzoni P, Villa A, Sobacchi C.

J Bone Miner Res. 2015 Mar 31. doi: 10.1002/jbmr.2517. [Epub ahead of print]

PMID:
25829125
2.

Elaidate, an 18-carbon trans-monoenoic fatty acid, but not physiological fatty acids increases intracellular Zn(2+) in human macrophages.

Zacherl JR, Tourkova I, St Croix CM, Robinson LJ, Peck Palmer OM, Mihalik SJ, Blair HC.

J Cell Biochem. 2015 Apr;116(4):524-32. doi: 10.1002/jcb.25002.

PMID:
25358453
3.

Follicle stimulating hormone receptor in mesenchymal stem cells integrates effects of glycoprotein reproductive hormones.

Tourkova IL, Witt MR, Li L, Larrouture Q, Liu L, Luo J, Robinson LJ, Blair HC.

Ann N Y Acad Sci. 2015 Jan;1335:100-9. doi: 10.1111/nyas.12502. Epub 2014 Aug 12.

PMID:
25118101
4.

Follistatin-like protein 1 regulates chondrocyte proliferation and chondrogenic differentiation of mesenchymal stem cells.

Chaly Y, Blair HC, Smith SM, Bushnell DS, Marinov AD, Campfield BT, Hirsch R.

Ann Rheum Dis. 2014 Mar 21. doi: 10.1136/annrheumdis-2013-204822. [Epub ahead of print]

PMID:
24641944
5.

Thyroid and bone: macrophage-derived TSH-β splice variant increases murine osteoblastogenesis.

Baliram R, Chow A, Huber AK, Collier L, Ali MR, Morshed SA, Latif R, Teixeira A, Merad M, Liu L, Sun L, Blair HC, Zaidi M, Davies TF.

Endocrinology. 2013 Dec;154(12):4919-26. doi: 10.1210/en.2012-2234. Epub 2013 Oct 18.

6.

Elaidate, an 18-carbon trans-monoenoic fatty acid, inhibits β-oxidation in human peripheral blood macrophages.

Zacherl JR, Mihalik SJ, Chace DH, Christensen TC, Robinson LJ, Blair HC.

J Cell Biochem. 2014 Jan;115(1):62-70. doi: 10.1002/jcb.24633.

PMID:
23904193
7.

RANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare disease.

Lo Iacono N, Pangrazio A, Abinun M, Bredius R, Zecca M, Blair HC, Vezzoni P, Villa A, Sobacchi C.

Clin Dev Immunol. 2013;2013:412768. doi: 10.1155/2013/412768. Epub 2013 May 15. Review.

8.

A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation.

Tantikanlayaporn D, Robinson LJ, Suksamrarn A, Piyachaturawat P, Blair HC.

Phytomedicine. 2013 Jun 15;20(8-9):676-82. doi: 10.1016/j.phymed.2013.02.008. Epub 2013 Apr 1.

9.

DNA damage drives accelerated bone aging via an NF-κB-dependent mechanism.

Chen Q, Liu K, Robinson AR, Clauson CL, Blair HC, Robbins PD, Niedernhofer LJ, Ouyang H.

J Bone Miner Res. 2013 May;28(5):1214-28. doi: 10.1002/jbmr.1851.

10.

Na+/H+ exchanger regulatory factor 1 (NHERF1) directly regulates osteogenesis.

Liu L, Alonso V, Guo L, Tourkova I, Henderson SE, Almarza AJ, Friedman PA, Blair HC.

J Biol Chem. 2012 Dec 21;287(52):43312-21. doi: 10.1074/jbc.M112.422766. Epub 2012 Oct 29.

11.

Vitamin C prevents hypogonadal bone loss.

Zhu LL, Cao J, Sun M, Yuen T, Zhou R, Li J, Peng Y, Moonga SS, Guo L, Mechanick JI, Iqbal J, Peng L, Blair HC, Bian Z, Zaidi M.

PLoS One. 2012;7(10):e47058. doi: 10.1371/journal.pone.0047058. Epub 2012 Oct 8.

12.

NHERF1 regulation of PTH-dependent bimodal Pi transport in osteoblasts.

Wang B, Yang Y, Liu L, Blair HC, Friedman PA.

Bone. 2013 Jan;52(1):268-77. doi: 10.1016/j.bone.2012.10.001. Epub 2012 Oct 7.

13.

Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling.

Baliram R, Sun L, Cao J, Li J, Latif R, Huber AK, Yuen T, Blair HC, Zaidi M, Davies TF.

J Clin Invest. 2012 Oct;122(10):3737-41. doi: 10.1172/JCI63948. Epub 2012 Sep 17.

14.

Osteopetrosis rescue upon RANKL administration to Rankl(-/-) mice: a new therapy for human RANKL-dependent ARO.

Lo Iacono N, Blair HC, Poliani PL, Marrella V, Ficara F, Cassani B, Facchetti F, Fontana E, Guerrini MM, Traggiai E, Schena F, Paulis M, Mantero S, Inforzato A, Valaperta S, Pangrazio A, Crisafulli L, Maina V, Kostenuik P, Vezzoni P, Villa A, Sobacchi C.

J Bone Miner Res. 2012 Dec;27(12):2501-10. doi: 10.1002/jbmr.1712.

PMID:
22836362
15.

Blocking FSH action attenuates osteoclastogenesis.

Zhu LL, Tourkova I, Yuen T, Robinson LJ, Bian Z, Zaidi M, Blair HC.

Biochem Biophys Res Commun. 2012 May 25;422(1):54-8. doi: 10.1016/j.bbrc.2012.04.104. Epub 2012 Apr 27.

16.

Gene disruption of the calcium channel Orai1 results in inhibition of osteoclast and osteoblast differentiation and impairs skeletal development.

Robinson LJ, Mancarella S, Songsawad D, Tourkova IL, Barnett JB, Gill DL, Soboloff J, Blair HC.

Lab Invest. 2012 Jul;92(7):1071-83. doi: 10.1038/labinvest.2012.72. Epub 2012 Apr 30.

17.

Special stem cells for bone.

Zaidi M, Sun L, Blair HC.

Cell Stem Cell. 2012 Mar 2;10(3):233-4. doi: 10.1016/j.stem.2012.02.012.

18.

Further evidence that FSH causes bone loss independently of low estrogen.

Iqbal J, Blair HC, Zallone A, Sun L, Zaidi M.

Endocrine. 2012 Apr;41(2):171-5. doi: 10.1007/s12020-012-9626-y. Epub 2012 Feb 21. No abstract available.

PMID:
22350658
19.

Skeletal receptors for steroid-family regulating glycoprotein hormones: A multilevel, integrated physiological control system.

Blair HC, Robinson LJ, Sun L, Isales C, Davies TF, Zaidi M.

Ann N Y Acad Sci. 2011 Dec;1240:26-31. doi: 10.1111/j.1749-6632.2011.06287.x. Review.

PMID:
22172036
20.

Calcium and bone disease.

Blair HC, Robinson LJ, Huang CL, Sun L, Friedman PA, Schlesinger PH, Zaidi M.

Biofactors. 2011 May-Jun;37(3):159-67. doi: 10.1002/biof.143. Epub 2011 Jun 14. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk